SciSight Ecosystem
WoS SCIE Q1Hybrid

Onkologe

Abbreviation (ISO):ONKOLOGE
Country: Germany•WoS SCIE Quartile: Q1•Identifier (ISSN):0947-8965(Print)/1433-0415(Online)•Articles / Year: 123
Clarivate Impact Factor (IF 2024)Q1
N/A

Leading citation impact metric from Clarivate Journal Citation Reports

H-Index (2021)
12

12 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
123articles/year
4.62% Gold OA•95.12% Original Research

Aims & Scope

Der Onkologe deals with relevant issues concerning the diagnosis and therapy of oncological diseases. Special emphasis is placed on oncology’s interfaces with the fields of internal medicine, radiology and surgery. This interdisciplinary journal addresses the needs of researchers and doctors working in the field of oncology. The core of each issue consists of comprehensive reviews on a specific topical issue. Here the focus is on providing evidenced based information on diagnostics and therapy relevant for daily practice. After the topics are selected by an independent editorial board, established experts prepare the articles for each issue. Contributions under the rubric 'Continuing Medical Education' present the verified results of scientific research and their integration into daily practice.

Topics Covered (Recognized by AI)
Medicine
Primary Research Areas

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
Updating
Minor Category (Specific Field):
Updating
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Springer Medizin
Publication Language
German
Frequency
Monthly
Founding Year
1996
Editorial Address
SPRINGER, 233 SPRING ST, NEW YORK , USA, NY, 10013
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

15 year
YearImpact FactorArticles / YearTotal Citations
20250——
20240.17——
20230.234——
20220.1377962
20210.248179250
20200.193187267
2019—181270
2018—178313
2017—145344
2016—171202
2015—143184
2014—17093
2013—141173
2012—142205
2011—146264
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Onkologe

WoS Q1
00112020202120222023202420250.00
Annual Impact Factor Metric
2025:0

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 15ae1835-323e-4c7e-91a6-9780c9bb34bd
Database Updated: 2026-09-28